Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit.

ESMO Open · 2021 · PMC8086015 · PMID 33887687

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the PRECISION V randomized phase II trial comparing cTACE with DEB-TACE with doxorubicin, DEB-TACE was associated with a numerically higher response rate and disease control rate, though this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.